Ashwin Chari

Dr. Ashwin Chari

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in Nature
Verified
Journal Article
Closed access
PDF file
KYKa Man Yip
Ka Man Yip
NFNiels Fischer
Niels Fischer
EPElham Paknia
Elham Paknia
ACAshwin Chari
Ashwin Chari
HSHolger Stark
Holger Stark

7 May 2021 in Science
Verified
Journal Article
Open access
PDF file
SGSebastian Guenther
Sebastian Guenther
PRPatrick Y. A. Reinke
Patrick Y. A. Reinke
YFYaiza Fernández-García
Yaiza Fernández-García
JLJulia Lieske
Julia Lieske
TLThomas J. Lane
Thomas J. Lane
AMAlke Meents
Alke Meents
A large-scale screen to target SARS-CoV-2: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome is initially expressed as two large polyproteins. Its main protease, M pro , is essential to yield functional viral proteins, making it a key drug target. Günther et al. used x-ray crystallography to screen more than 5000 compounds that are either approved drugs or drugs in clinical trials. The screen identified 37 compounds that bind to M pro . High-resolution structures showed that most compounds bind at the active site but also revealed two allosteric sites where binding of a drug causes conformational changes that affect the active site. In cell-based assays, seven compounds had antiviral activity without toxicity. The most potent, calpeptin, binds covalently in the active site, whereas the second most potent, pelitinib, binds at an allosteric site. Science , this issue p. 642

5 August 2016 in Science
Verified
Journal Article
Closed access
PDF file
JSJil Schrader
Jil Schrader
FHFabian Henneberg
Fabian Henneberg
RMRicardo A. Mata
Ricardo A. Mata
KTKai Tittmann
Kai Tittmann
TSThomas R. Schneider
Thomas R. Schneider
ACAshwin Chari
Ashwin Chari
Insights into proteasome inhibition: Proteasomes are large protein complexes that degrade and remove proteins to maintain proper cellular physiology and growth. Proteasomes are a validated target for anticancer therapy, but drug design has been hampered by poor understanding of how inhibitors interact with the active site. Schrader et al. succeeded in crystallizing various proteasome-inhibitor complexes. They subsequently obtained crystal structures for the native human proteasome and eight different inhibitor complexes at resolutions between 1.9 and 2.1 Å. The inhibitors sampled include drugs that are approved or in trial for cancer treatment. Science , this issue p. 594

3 August 2015 in Nature Methods
Verified
Journal Article
Closed access
PDF file
ACAshwin Chari
Ashwin Chari
DHDavid Haselbach
David Haselbach
JKJan-Martin Kirves
Jan-Martin Kirves
JOJuergen Ohmer
Juergen Ohmer
EPElham Paknia
Elham Paknia
HSHolger Stark
Holger Stark

21 June 2023 in Journal of Synchrotron Radiation
Verified
Journal Article
Open access
PDF file
TDTilman Donath
Tilman Donath
DJDubravka Šišak Jung
Dubravka Šišak Jung
Max BurianMax Burian
Max Burian
VRValeria Radicci
Valeria Radicci
PZPietro Zambon
Pietro Zambon
CSClemens Schulze-Briese
Clemens Schulze-Briese
The ability to utilize a hybrid-photon-counting detector to its full potential can significantly influence data quality, data collection speed, as well as development of elaborate data acquisition schemes. This paper facilitates the optimal use of EIGER2 detectors by providing theory and practical advice on (i) the relation between detector design, technical specifications and operating modes, (ii) the use of corrections and calibrations, and (iii) new acquisition features: a double-gating mode, 8-bit readout mode for increasing temporal resolution, and lines region-of-interest readout mode for frame rates up to 98 kHz. Examples of the implementation and application of EIGER2 at several synchrotron sources (ESRF, PETRA III/DESY, ELETTRA, AS/ANSTO) are presented: high accuracy of high-throughput data in serial crystallography using hard X-rays; suppressing higher harmonics of undulator radiation, improving peak shapes, increasing data collection speed in powder X-ray diffraction; faster ptychography scans; and cleaner and faster pump-and-probe experiments.

24 September 2022
Verified
Book Chapter
Closed access
PDF file
AGAybeg N. Günenc
Aybeg N. Günenc
BGBenjamin Graf
Benjamin Graf
HSHolger Stark
Holger Stark
ACAshwin Chari
Ashwin Chari